Bulut Gökten, Dilara, and Rıdvan Mercan. “Clinical Outcomes After Switching from Originator Infliximab to the Biosimilar Ixifi in Patients With Axial Spondyloarthritis: A Single-Center Study from Türkiye”. Rheumatology (Bulgaria) 34, no. 1 (May 1, 2026): 4–20. Accessed October 25, 2026. https://rheumatologybg.org/journal/rbj/article/view/100.